Still looking into this report.... but here's some "hot takes" so far:
Negatives:
* Income statement is substantially worse than last year when adjusting for the good will write-off... to the extent this matters
* 30% increase in cash finance costs
Other than that looks broadly positive...
Positives:
* if you look at the ratio of current WIP to non-current WIP theres a strong move towards current (realisable within the year). For the most part this is positive.
* Debt is still climbing but at a lower rate than in the past years
*Operating cashflow is climbing
*acquisition costs and deferred payments to acquired businesses are way down. .. at this point i think thats a good thing.
- Forums
- ASX - By Stock
- SHJ
- Ann: 2018 Annual Report
Ann: 2018 Annual Report, page-2
-
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHJ (ASX) to my watchlist
(20min delay)
|
|||||
Last
85.0¢ |
Change
-0.010(1.16%) |
Mkt cap ! $147.2M |
Open | High | Low | Value | Volume |
86.0¢ | 86.0¢ | 85.0¢ | $24.3K | 28.48K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 85.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
87.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.850 |
1 | 10000 | 0.810 |
2 | 3474 | 0.800 |
2 | 1948 | 0.740 |
2 | 10715 | 0.700 |
Price($) | Vol. | No. |
---|---|---|
0.870 | 10000 | 1 |
0.875 | 348 | 1 |
0.880 | 3410 | 1 |
0.890 | 44140 | 1 |
0.900 | 25834 | 3 |
Last trade - 14.57pm 13/11/2024 (20 minute delay) ? |
Featured News
SHJ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online